Works matching IS 2160763X AND DT 2019 AND VI 8 AND IP 6

Results: 15

The Effect of a High‐Fat Meal on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 734, doi. 10.1002/cpdd.641

By:

Tugnait, Meera;
Gupta, Neeraj;
Hanley, Michael J.;
Venkatakrishnan, Karthik;
Sonnichsen, Daryl;
Kerstein, David;
Dorer, David J.;
Narasimhan, Narayana

Publication type:

Article

Pharmacokinetics, Safety, and Tolerability Evaluation of Single and Multiple Doses of GSK3342830 in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 754, doi. 10.1002/cpdd.637

By:

Tenero, David;
Farinola, Nicholas;
Berkowitz, Elchonon M.;
Tiffany, Courtney A.;
Qian, Yanwen;
Xue, Zhengyu;
Raychaudhuri, Aparna;
Gardiner, David F.

Publication type:

Article

Population Pharmacokinetic Analysis of Daclatasvir, Asunaprevir, and Beclabuvir Combination in HCV‐Infected Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 802, doi. 10.1002/cpdd.649

By:

Osawa, Mayu;
Ueno, Takayo;
Shiozaki, Tomomi;
Ishikawa, Hiroki;
Li, Hanbin;
Garimella, Tushar

Publication type:

Article

No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 818, doi. 10.1002/cpdd.648

By:

Choi, Taylor;
Komirenko, Allison S.;
Riddle, Valerie;
Kim, Aryun;
Dhuria, Shyeilla V.

Publication type:

Article

Effect of Rifampicin on the Pharmacokinetics of a Single Dose of Vemurafenib in Patients With BRAF<sup>V600</sup> Mutation–Positive Metastatic Malignancy.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 837, doi. 10.1002/cpdd.643

By:

Zhang, Weijiang;
McIntyre, Christine;
Forbes, Harper;
Gaafar, Rabab;
Kohail, Hanaa;
Beck, J. Thaddeus;
Plestina, Stjepko;
Bertran, Enric;
Riehl, Todd

Publication type:

Article

Correction to: Pharmacokinetics and Bioavailability of a New Testosterone Gel Formulation in Comparison to Testogel® in Healthy Men.

Published in:: Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 844, doi. 10.1002/cpdd.705
Publication type:: Article

Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed‐Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions—Data From 2 Single‐Center, Single‐Dose, Randomized Crossover Studies in Healthy Volunteers

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 742, doi. 10.1002/cpdd.672

By:

Weiser, Thomas;
Schepers, Cornelia;
Mück, Tobias;
Lange, Robert

Publication type:

Article

Drug‐Drug Interactions of Tacrolimus or Cyclosporine With Glecaprevir and Pibrentasvir in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 779, doi. 10.1002/cpdd.671

By:

Kosloski, Matthew P.;
Zhao, Weihan;
Li, Hong;
Pugatch, David;
Asatryan, Armen;
Kort, Jens;
Mensa, Federico J.;
Liu, Wei

Publication type:

Article

A Randomized, Double‐Blind, Placebo‐Controlled, First‐Time‐in‐Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 790, doi. 10.1002/cpdd.670

By:

Han, Kelong;
Cremer, Jennifer;
Elston, Robert;
Oliver, Stuart;
Baptiste‐Brown, Sharon;
Chen, Shuguang;
Gardiner, David;
Davies, Matt;
Saunders, Joanne;
Hamatake, Robert;
Losos, Jan;
Leivers, Martin;
Hood, Steve;
Berg, Frans;
Paff, Melanie;
Ritter, James M.;
Theodore, Dickens

Publication type:

Article

Randomized Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Topical Daprodustat in Healthy Volunteers and in Patients With Diabetic Foot Ulcers.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 765, doi. 10.1002/cpdd.654

By:

Olson, Eric;
Mahar, Kelly M.;
Morgan, Lisa;
Fillmore, Christina;
Holland, Claire;
Lavery, Lawrence

Publication type:

Article

Single‐Dose Pharmacokinetic Properties and Relative Bioavailability of Different Formulations of Posaconazole Oral Suspension in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 827, doi. 10.1002/cpdd.636

By:

Vuletić, Lucija;
Herceg, Marina;
Ferderber, Kristina;
Tunjić, Iva;
Rizea‐Savu, Simona;
Duna, Simona Nicoleta;
Cetina‐Čižmek, Biserka;
Filipović‐Grčić, Jelena

Publication type:

Article

Pharmacokinetics of Single and Repeat Doses of Fluticasone Furoate/Umeclidinium/Vilanterol in Healthy Chinese Adults.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 721, doi. 10.1002/cpdd.626

By:

Li, Yan;
Li, Huafang;
Sheng, Yucheng;
Du, Xin;
Yao, Yuhui;
Luo, Xian;
Ma, Peiming

Publication type:

Article

Bioequivalence of Sarpogrelate in Healthy Chinese Subjects Under Fasting and Fed Conditions: A 4‐Way Replicate Crossover Investigation by a Reference‐Scaled Average Bioequivalence Approach.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 713, doi. 10.1002/cpdd.624

By:

Ding, Y.H.;
Liu, B.;
Lou, J.F.;
Sun, J.X.;
Wu, M.;
Zhu, X.X.;
Chen, G.L.;
Zhang, H.;
Li, X.J.;
Chen, H.;
Liu, C.J.;
Shen, Z.W.;
Li, C.Y.

Publication type:

Article

Relative and Absolute Bioavailability Study of Emicizumab to Bridge Drug Products and Subcutaneous Injection Sites in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 702, doi. 10.1002/cpdd.617

By:

Kotani, Naoki;
Yoneyama, Koichiro;
Kawakami, Nobuhiko;
Shimuta, Tohru;
Fukase, Hiroyuki;
Kawanishi, Takehiko

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 697, doi. 10.1002/cpdd.594
Publication type:: Article